TY - JOUR
T1 - State of Lung Cancer in Egypt
T2 - Moving Towards Improved Guidelines for Prevention, Screening, Treatment, and Clinical Care Programs
AU - Karim, Nagla Abdel
AU - Rabea, Ahmed Magdy
AU - Mack, Philip C
AU - Subramanian, Janakiraman
AU - Khalil, Ehab
AU - Sherif, Mai
AU - Marawan, Radwa
AU - Gaafar, Tagrid
AU - Shash, Lobna
AU - Suzuki, Kei
AU - Ahluwalia, Manmeet
AU - Wahba, Hisham
AU - Aboelela, Salma
AU - Al Ahmadi, Asrar
AU - Al Husaini, Hamed
AU - Mohsen, Nada
AU - Khaled, Rana
AU - Kassem, Neemat
AU - Khaled, Hussein
AU - El Said, Noha
AU - Zakhary, Nadia
AU - Shoukry, Dina
AU - ElSadieque, Alaa Abdullah
AU - Alsedfy, M Yasser
AU - Islam, Shaheen
AU - ElSherbiny, Hend
AU - El Deftar, Mervat
AU - Awad, Noha
AU - Mohamed, Abdel Rahman
AU - Gandara, David
AU - Kelly, Karen
AU - Sen, Triparna
N1 - © 2024 The Authors.
PY - 2025/1
Y1 - 2025/1
N2 - Lung cancer remains a leading cause of cancer-related mortality globally and presents significant challenges in Egypt. In 2023, the first annual meeting of the Thoracic Oncology Multidisciplinary Faculty, organized by the Egyptian Cancer Research Network and the Egyptian Society of Respiratory Neoplasms, was held in Cairo, Egypt. The meeting aimed to address gaps in lung cancer management across Egypt and the broader Middle East and North Africa region. The discussions focused on the challenges posed by NSCLC and SCLC and emphasized the need for enhanced prevention, early detection, and treatment strategies. Key areas of concern include limited access to advanced diagnostics, such as comprehensive genomic profiling, and the underutilization of targeted therapies and immunotherapies, mainly owing to financial barriers. The meeting highlighted the importance of strengthening lung cancer screening programs, improving smoking cessation efforts, and addressing environmental risk factors like air pollution. Furthermore, the event underscored the need for greater research and collaboration, particularly in areas like precision oncology. The conference concluded with strategic recommendations to improve lung cancer prevention, screening, and treatment, aligning Egypt's lung cancer care with global advancements and ensuring equitable access to cutting-edge therapies.
AB - Lung cancer remains a leading cause of cancer-related mortality globally and presents significant challenges in Egypt. In 2023, the first annual meeting of the Thoracic Oncology Multidisciplinary Faculty, organized by the Egyptian Cancer Research Network and the Egyptian Society of Respiratory Neoplasms, was held in Cairo, Egypt. The meeting aimed to address gaps in lung cancer management across Egypt and the broader Middle East and North Africa region. The discussions focused on the challenges posed by NSCLC and SCLC and emphasized the need for enhanced prevention, early detection, and treatment strategies. Key areas of concern include limited access to advanced diagnostics, such as comprehensive genomic profiling, and the underutilization of targeted therapies and immunotherapies, mainly owing to financial barriers. The meeting highlighted the importance of strengthening lung cancer screening programs, improving smoking cessation efforts, and addressing environmental risk factors like air pollution. Furthermore, the event underscored the need for greater research and collaboration, particularly in areas like precision oncology. The conference concluded with strategic recommendations to improve lung cancer prevention, screening, and treatment, aligning Egypt's lung cancer care with global advancements and ensuring equitable access to cutting-edge therapies.
U2 - 10.1016/j.jtocrr.2024.100776
DO - 10.1016/j.jtocrr.2024.100776
M3 - Article
C2 - 39790369
SN - 2666-3643
VL - 6
SP - 100776
JO - JTO clinical and research reports
JF - JTO clinical and research reports
IS - 1
ER -